Preclinical Evaluation of (203/212)Pb-Labeled Low-Molecular-Weight Compounds for Targeted Radiopharmaceutical Therapy of Prostate Cancer

Targeted radiopharmaceutical therapy (TRT) using α-particle radiation is a promising approach for treating both large and micrometastatic lesions. We developed prostate-specific membrane antigen (PSMA)–targeted low-molecular-weight agents for (212)Pb-based TRT of patients with prostate cancer (PC) b...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Nucl Med
Main Authors: Banerjee, Sangeeta Ray, Minn, Il, Kumar, Vivek, Josefsson, Anders, Lisok, Ala, Brummet, Mary, Chen, Jian, Kiess, Ana P., Baidoo, Kwamena, Brayton, Cory, Mease, Ronnie C., Brechbiel, Martin, Sgouros, George, Hobbs, Robert F., Pomper, Martin G.
Formato: Artigo
Idioma:Inglês
Publicado: Society of Nuclear Medicine 2020
Assuntos:
Theranostics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6954458/
https://ncbi.nlm.nih.gov/pubmed/31253744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.119.229393
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares